INTRODUCING OVAGEN...

• Ovagen is a biotechnology company that has developed a process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry.

• Germ-free eggs are preferred as currently eggs produced from normal or SPF laying flocks can be infected with bacteria and viruses

• Germ-free eggs provide many advantages over current sources of eggs including:
A safe, biosecure, large scale, flexible and cost effective biomanufacturing platform for the production of vaccines and therapeutic proteins

• No contamination from eggs of batches of vaccines / therapeutic proteins / foods
- Leads to cost saving and greater continuity of supply of finished product
- Removes risks of production plant contamination from eggs

• GF technology enables removal of infections in conventional/SPF genetic lines (derivation and upgrading)

• GF eggs are fully compliant with USDA Memo 800.65 and European Pharmacopoeia requirements.

NEW BUILDING

August 2008 (2500msq)
First generation germ-free flocks,
Isolators, Incubators
Laboratories
Egg processing
R&D
Head Office.

CONTACT

Ovagen Group Limited
Carrentrila,
Ballina,
Co. Mayo,
Ireland.

T. +353 (0)96 75579
E. info@ovagen.com